Spectral AI, Inc. (MDAI) vs OKYO Pharma Limited (OKYO)
A side-by-side comparison of Spectral AI, Inc. and OKYO Pharma Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDAI
Spectral AI, Inc.
$1.70HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
OKYO
OKYO Pharma Limited
$1.48HealthcareDelayed quote: Oct 6, 2026, 12:58 PM EDT
Total return — MDAI vs OKYO
growth of $100 · dividends reinvested · last 4yMDAI -82.7% (-35.5%/yr)OKYO -59.4% (-20.2%/yr)OKYO compounded faster over this window
MDAI OKYO
MDAI vs OKYO: by the numbers
- •OKYO is the larger company ($57M vs $54M market cap).
- •Both run net losses; OKYO's is the smaller (0.00% vs -69.27% net margin).
Metrics side by side
Valuation
| Metric | MDAI | OKYO |
|---|---|---|
| P/S ratio | 3.57 | N/A |
| P/B ratio | N/A | 4.60 |
Profitability
| Metric | MDAI | OKYO |
|---|---|---|
| Gross margin | 41.51% | 0.00% |
| Operating margin | -43.78% | 0.00% |
| Net margin | -69.27% | 0.00% |
| ROE | N/A | -72.55% |
| ROIC | -353.68% | -68.91% |
Growth (annualized)
| Metric | MDAI | OKYO |
|---|---|---|
| Total return CAGR (5Y) | -29.57% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.